Packaging central to supply chain security

08 September 2014

Pharmaceutical companies must constantly respond to changes in regulation, many of which address supply chain security and require changes to product packaging. Jim Banks looks at the implications of new legislation such as Europe’s Falsified Medicines Directive and the packaging innovations that are helping companies keep up with the demands of traceability and tamper-evident solutions. Regulation is necessarily a moving target and the pharma industry has no choice but to keep up. To do so, it must adopt a collaborative approach with packaging companies working to innovate and to adopt the technologies that will keep the industry compliant (Packaging Today, 14 August 2014).
Click here for the full article.

This item is also included in our monthly overview, the NVC Members-only Update. If you have any questions, please contact us: info@nvc.nl, +31-(0)182-512411.